Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 2
1950 1
1959 1
1962 2
1963 1
1964 1
1965 2
1967 1
1968 2
1969 1
1970 3
1971 1
1972 2
1974 1
1975 2
1976 3
1977 1
1978 1
1979 1
1980 2
1981 1
1983 3
1984 1
1985 2
1986 3
1987 1
1989 1
1990 2
1991 6
1994 1
1995 3
1996 1
1997 2
1998 2
1999 1
2000 2
2001 3
2002 3
2003 9
2004 13
2005 14
2006 13
2007 19
2008 12
2009 10
2010 11
2011 16
2012 12
2013 17
2014 16
2015 22
2016 19
2017 18
2018 20
2019 18
2020 23
2021 37
2022 38
2023 24
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. Among authors: balazs ab. Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. Cell. 2021. PMID: 33412089 Free PMC article.
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs.
Johannes JW, Balazs A, Barratt D, Bista M, Chuba MD, Cosulich S, Critchlow SE, Degorce SL, Di Fruscia P, Edmondson SD, Embrey K, Fawell S, Ghosh A, Gill SJ, Gunnarsson A, Hande SM, Heightman TD, Hemsley P, Illuzzi G, Lane J, Larner C, Leo E, Liu L, Madin A, Martin S, McWilliams L, O'Connor MJ, Orme JP, Pachl F, Packer MJ, Pei X, Pike A, Schimpl M, She H, Staniszewska AD, Talbot V, Underwood E, Varnes JG, Xue L, Yao T, Zhang K, Zhang AX, Zheng X. Johannes JW, et al. Among authors: balazs a. J Med Chem. 2021 Oct 14;64(19):14498-14512. doi: 10.1021/acs.jmedchem.1c01012. Epub 2021 Sep 27. J Med Chem. 2021. PMID: 34570508
Delivery platforms for broadly neutralizing antibodies.
Joshi LR, Gálvez NMS, Ghosh S, Weiner DB, Balazs AB. Joshi LR, et al. Among authors: balazs ab. Curr Opin HIV AIDS. 2023 Jul 1;18(4):191-208. doi: 10.1097/COH.0000000000000803. Epub 2023 May 15. Curr Opin HIV AIDS. 2023. PMID: 37265268 Review.
SARS-CoV-2-specific ELISA development.
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G. Roy V, et al. Among authors: balazs a. J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. J Immunol Methods. 2020. PMID: 32780998 Free PMC article.
Self-regulated non-reciprocal motions in single-material microstructures.
Li S, Lerch MM, Waters JT, Deng B, Martens RS, Yao Y, Kim DY, Bertoldi K, Grinthal A, Balazs AC, Aizenberg J. Li S, et al. Among authors: balazs ac. Nature. 2022 May;605(7908):76-83. doi: 10.1038/s41586-022-04561-z. Epub 2022 May 4. Nature. 2022. PMID: 35508775
De novo hematopoiesis from the fetal lung.
Yeung AK, Villacorta-Martin C, Lindstrom-Vautrin J, Belkina AC, Vanuytsel K, Dowrey TW, Ysasi AB, Bawa P, Wang F, Vrbanac V, Mostoslavsky G, Balazs AB, Murphy GJ. Yeung AK, et al. Among authors: balazs ab. Blood Adv. 2023 Nov 28;7(22):6898-6912. doi: 10.1182/bloodadvances.2022008347. Blood Adv. 2023. PMID: 37729429 Free PMC article.
Strain-Stiffening Hydrogels with Dynamic, Secondary Cross-Linking.
Sonu KP, Zhou L, Biswas S, Klier J, Balazs AC, Emrick T, Peyton SR. Sonu KP, et al. Among authors: balazs ac. Langmuir. 2023 Feb 21;39(7):2659-2666. doi: 10.1021/acs.langmuir.2c03117. Epub 2023 Feb 8. Langmuir. 2023. PMID: 36752594
Reconfigurable soft matter.
Balazs AC, Aizenberg J. Balazs AC, et al. Soft Matter. 2014 Mar 7;10(9):1244-5. doi: 10.1039/c4sm90006e. Soft Matter. 2014. PMID: 24651948 No abstract available.
Engineering humoral immunity as prophylaxis or therapy.
Deal CE, Balazs AB. Deal CE, et al. Among authors: balazs ab. Curr Opin Immunol. 2015 Aug;35:113-22. doi: 10.1016/j.coi.2015.06.014. Epub 2015 Jul 14. Curr Opin Immunol. 2015. PMID: 26183209 Free PMC article. Review.
441 results